Hemangiosarcoma: Clinical Trials

2 trials for Hemangiosarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Terminated 2
Phase 21Terminated 1

Follow Hemangiosarcoma: new trials by email Literature Review of Hemangiosarcoma trials Research Report on Hemangiosarcoma

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma
doxorubicin hydrochloride, trabectedin, laboratory biomarker analysis - Sarcoma
Phase 2 / Phase 3TerminatedEuropean Organisation for Research and Treatment of Cancer - EORTC1332011-05-012014-08-08
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
cyproheptadine hydrochloride, placebo - Cancer
Phase 3TerminatedUniversity of South Florida222010-06-012015-07-02

Narrower conditions

Fibrosarcoma (2)  ·  Sarcoma (2)  ·  Astrocytoma (1)  ·  Body Weight Changes (1)  ·  Bone Neoplasms (1)  ·  Cachexia (1)  ·  Chondrosarcoma (1)  ·  Chondrosarcoma, Extraskeletal Myxoid (1)  ·  Choroid Plexus Neoplasms (1)  ·  Desmoplastic Small Round Cell Tumor (1)  ·  Familial ependymoma (1)  ·  Glioblastoma (1)  ·  Hemangiopericytoma, Malignant (1)  ·  Hepatoblastoma (1)

Broader conditions

Neoplasms by Histologic Type (2)  ·  Neoplasms, Connective Tissue (2)  ·  Neoplasms, Connective and Soft Tissue (2)  ·  Neoplasms, Fibrous Tissue (2)  ·  Neoplasms, Nerve Tissue (2)  ·  Neoplasms, Vascular Tissue (2)  ·  Nervous System Diseases (2)  ·  Nervous System Neoplasms (2)  ·  Peripheral Nervous System Neoplasms (2)  ·  Body Weight (1)  ·  Bone Diseases (1)  ·  Brain Diseases (1)  ·  Brain Neoplasms (1)  ·  Central Nervous System Diseases (1)  ·  Central Nervous System Neoplasms (1)

Interventions

Cyproheptadine (1)  ·  Doxorubicin (1)  ·  Trabectedin (1)

Sponsors

European Organisation for Research and Treatment of Cancer - EORTC (1)  ·  University of South Florida (1)

Countries

United States (2)  ·  Austria (1)  ·  Belgium (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Slovakia (1)  ·  Spain (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

James E. Butrynski, MD (1)  ·  Jeffrey P. Krischer, PhD (1)  ·  Nguyen Binh Bui, MD (1)

NIH funding

2009 (1), U10CA081920 (1)